Comparative Pharmacology
Head-to-head clinical analysis: LANTHANUM CARBONATE versus VELPHORO.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LANTHANUM CARBONATE versus VELPHORO.
LANTHANUM CARBONATE vs VELPHORO
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lanthanum carbonate dissociates in the acidic gastric environment to release lanthanum ions, which bind to dietary phosphate in the gastrointestinal tract, forming insoluble lanthanum-phosphate complexes that are excreted in feces, reducing serum phosphate levels.
Iron-based phosphate binder that forms non-absorbable complexes with dietary phosphate in the gastrointestinal tract, reducing serum phosphate levels.
Oral: 500-1000 mg three times daily with meals, titrated based on serum phosphate levels; maximum 3000 mg/day.
1-2 tablets (500-1000 mg iron) orally three times daily with meals; titrate to achieve serum phosphorus target.
None Documented
None Documented
Clinical Note
moderateLanthanum carbonate + Gatifloxacin
"The serum concentration of Gatifloxacin can be decreased when it is combined with Lanthanum carbonate."
Clinical Note
moderateLanthanum carbonate + Rosoxacin
"The serum concentration of Rosoxacin can be decreased when it is combined with Lanthanum carbonate."
Clinical Note
moderateLanthanum carbonate + Levofloxacin
"The serum concentration of Levofloxacin can be decreased when it is combined with Lanthanum carbonate."
Clinical Note
moderateTerminal half-life not clinically defined due to minimal systemic absorption; effectively acts locally in GI tract.
Not applicable (non-absorbed drug acting locally in GI tract; no systemic half-life).
Primarily fecal (>99%) as unabsorbed drug. Minimal renal elimination (<1%).
Primarily fecal as unabsorbed drug; negligible renal excretion (<0.1%).
Category C
Category C
Phosphate Binder
Phosphate Binder
Lanthanum carbonate + Trovafloxacin
"The serum concentration of Trovafloxacin can be decreased when it is combined with Lanthanum carbonate."